FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

P Berglund

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Paula Colmenero; P Berglund; Taku Kambayashi; Peter Biberfeld; Peter Liljeström; Mikael Jondal
Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.
C Andersson; Nina-Maria Vasconcelos; Maria Sievertzon; D Haddad; Sissela Liljeqvist; P Berglund; Peter Liljeström; Niklas Ahlborg; Stefan Ståhl; Klavs Berzins
Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.
Charlotta Nilsson; Barbro Mäkitalo; P Berglund; Françoise Bex; Peter Liljeström; Gerd Sutter; Volker Erfle; Peter Ten Haaft; Jonathan Luke Heeney; Gunnel Biberfeld; Rigmor Thorstensson
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of P Berglund (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Paula Colmenero; P Berglund; Taku Kambayashi; Peter Biberfeld; Peter Liljeström; Mikael Jondal
Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.
Gene therapy 2001;8(17):1307-14.
2001: C Andersson; Nina-Maria Vasconcelos; Maria Sievertzon; D Haddad; Sissela Liljeqvist; P Berglund; Peter Liljeström; Niklas Ahlborg; Stefan Ståhl; Klavs Berzins
Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.
Scandinavian journal of immunology 2001;54(1-2):117-24.
2001: Charlotta Nilsson; Barbro Mäkitalo; P Berglund; Françoise Bex; Peter Liljeström; Gerd Sutter; Volker Erfle; Peter Ten Haaft; Jonathan Luke Heeney; Gunnel Biberfeld; Rigmor Thorstensson
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
Vaccine 2001;19(25-26):3526-36.
2001: Marina N Fleeton; Margaret Chen; P Berglund; Gary H Rhodes; S E Parker; M Murphy; Gregory J Atkins; Peter Liljeström
Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
The Journal of infectious diseases 2001;183(9):1395-8.
2000: Taku Kambayashi; Erika Assarsson; Jakob Michaëlsson; P Berglund; Alexander Diehl; Benedict J Chambers; Hans-Gustaf Ljunggren
Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):4964-9.
2000: Jonathan Luke Heeney; Gerrit Koopman; Brigitte Rosenwirth; Willy M J M Bogers; J van Dijk; Ivonne G Nieuwenhuis; Henk Niphuis; Peter Ten Haaft; T Hanke; Gary H Rhodes; P Berglund; Arsène Burny; Françoise Bex; Gerd Sutter; Peter Liljeström
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.
Journal of medical primatology 2000;29(3-4):268-73.
1999: Brigitte Rosenwirth; Willy M J M Bogers; Ivonne G Nieuwenhuis; Peter Ten Haaft; Henk Niphuis; EM Kuhn; N Bischofberger; Volker Erfle; Gerd Sutter; P Berglund; Peter Liljestrom; Klaus Uberla; Jonathan Luke Heeney
An anti-HIV strategy combining chemotherapy and therapeutic vaccination.
Journal of medical primatology 1999;28(4-5):195-205.
1999: P Berglund; Marina N Fleeton; C Smerdou; Peter Liljeström
Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice.
Vaccine 1999;17(5):497-507.
1998: P Berglund; C Smerdou; Marina N Fleeton; I Tubulekas; Peter Liljeström
Enhancing immune responses using suicidal DNA vaccines.
Nature biotechnology 1998;16(6):562-5.
1997: P Berglund; M Quesada-Rolander; P Putkonen; Gunnel Biberfeld; Rigmor Thorstensson; Peter Liljeström
Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.
AIDS research and human retroviruses 1997;13(17):1487-95.
1997: J Zhang; C Asselin-Paturel; Françoise Bex; J Bernard; J Chehimi; F Willems; Anne Caignard; P Berglund; Peter Liljeström; Arsène Burny; Salem Chouaib
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
Gene therapy 1997;4(4):367-74.
1996: P Berglund; I Tubulekas; Peter Liljeström
Alphaviruses as vectors for gene delivery.
Trends in biotechnology 1996;14(4):130-4.
1996: S P Mossman; Françoise Bex; P Berglund; J Arthos; S P O'Neil; D Riley; D H Maul; Claudine Bruck; P Momin; Arsène Burny; P N Fultz; James I Mullins; Peter Liljeström; Edward A Hoover
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Journal of virology 1996;70(3):1953-60.
1995: X Zhou; P Berglund; H Zhao; Peter Liljeström; Mikael Jondal
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):3009-13.
1994: X Zhou; P Berglund; Gary H Rhodes; S E Parker; Mikael Jondal; Peter Liljeström
Self-replicating Semliki Forest virus RNA as recombinant vaccine.
Vaccine 1994;12(16):1510-4.
1993: P Berglund; Mathilda Sjöberg; Henrik Garoff; Gregory J Atkins; Brian J Sheahan; Peter Liljeström
Semliki Forest virus expression system: production of conditionally infectious recombinant particles.
Bio/technology (Nature Publishing Company) 1993;11(8):916-20.